Business
ARIUS to present at BIO 2007 Business Forum
ARIUS to present at BIO 2007 Business Forum.
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\nTORONTO, May 3 /CNW/ - ARIUS Research Inc., ("ARIUS" or the "Company")\n(TSX: ARI), announced today that David Young, MD, President and Chief\nExecutive Officer of ARIUS, has been invited to speak during the Business\nForum at the "BIO 2007" conference.\n\n\nDr. Young will present on Tuesday, May 8th at 3:45pm Eastern Time and\nwill be available following his presentation. The conference is being held at\nthe Boston Convention & Exhibition Center in Boston, Massachusetts. Dr. Young\nwill provide an overview of the company's business and unique technology and\nwill update the audience on milestones for the company's lead programs in\ncancer. ARIUS has three lead programs focused on treatments for breast,\nprostate, colon and pancreatic cancers and is actively pursuing partnering\nopportunities to move the pipeline forward.\n\n\nThe BIO International Convention offers attendees an opportunity to meet\nface-to-face with every key player in the biotechnology industry. Program\nparticipants include researchers, academia, entrepreneurs, venture\ncapitalists, and others who are recognized for their vision and achievement.\n\n\nAbout ARIUS\n\n\nARIUS is a biotechnology company discovering and developing the next wave\nof antibody therapeutics. Established in 1999, ARIUS has built a proprietary\ntechnology platform, FunctionFIRST(TM), that rapidly identifies and selects\nantibodies based on their functional ability to affect disease. This antibody\ngeneration engine has enabled ARIUS to assemble a portfolio of more than 400\nantibody candidates. In addition to the antibodies it is developing in-house,\nARIUS has ongoing partnerships with key biotechnology and drug development\ncompanies. ARIUS is listed on the TSX under the symbol "ARI". For further\ninformation, visit www.ariusresearch.com\n\n\nForward-Looking Statements\n\n\nCertain statements in this news release constitute "forward-looking\nstatements" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimite...